Monday, 25 August 2014

JAPAN OFFERS UNAPPROVED EBOLA DRUG


Japan could allegedly provide the self-developed unapproved drug to help treat Ebola and ready to cooperate with the World Health Organization (WHO) by offering their solution.



T-705 is the developmental code for the influenza drug favipiravir. The developers, a subsidiary of Fujifilm Holdings Corp., and the U.S. partner MediVector are currently negotiating with the U.S. Food and Drug Administration on the permission to to expand the use of favipiravir to fight Ebola.

According to the official, the effectiveness of T-705 was confirmed in experiments on mice. The company representative stated that it has favipiravir stock for more than twenty thousand patients.

No comments:

Post a Comment